Drugs Made In America Acq...

NASDAQ: DMAA · Real-Time Price · USD
10.27
-0.01 (-0.10%)
At close: Aug 15, 2025, 3:56 PM
10.27
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT

Drugs Made In America Acquisition Ordinary Shares Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024
Cash & Equivalents
923.00 n/a 2.1K 18.10
Short-Term Investments
n/a 1.35K n/a n/a
Long-Term Investments
233.59M n/a n/a n/a
Other Long-Term Assets
-852.38K 545.83 424.04K 112.96
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
71.02K 4.99 2.1K 78.10
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
232.74M 545.83 424.04K 112.96
Total Assets
232.81M 550.82 426.14K 191.06
Account Payables
132.48K n/a n/a n/a
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
60.9K 662.32 552.01K 210.09
Other Current Liabilities
n/a 56.06 38.98K 0.90
Total Current Liabilities
347.37K 795.67 591K 210.99
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
6.9M n/a n/a n/a
Total Long-Term Liabilities
6.9M n/a n/a n/a
Total Liabilities
7.25M 795.67 591K 210.99
Total Debt
60.9K 662.32 552.01K 210.09
Common Stock
232.74M 986.00 986.00 0.99
Retained Earnings
-6.33M -279 -199.86K -54.93
Comprehensive Income
n/a n/a n/a -0.00
Shareholders Equity
225.56M -244 -164.86K -19.93
Total Investments
233.59M 1.35K n/a n/a